Enzo Biochem And Flagship Biosciences LLC Partner To Provide Tissue-Based Companion Diagnostics Offering Complete Solution For In Situ Hybridization Development To Pharmaceutical Companies

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in tissue-based companion diagnostics that will enable personalized diagnosis and treatment of disease. The firms are working jointly with pharmaceutical clients that require an independent complete solution to the delivery of an in situ hybridization (ISH) companion diagnostic, which ultimately could have a major impact on drug development.

Help employers find you! Check out all the jobs and post your resume.